Abstract
Introduction. The armed invasion of Ukraine (since February 2022) has caused an unprecedented convergence of three oncogenic factors: chemical contamination from missile and drone strikes, the radiation legacy of the 1986 Chornobyl catastrophe, and mass chronic psychological stress among civilians and military personnel. While each factor is individually well-studied, their pathophysiological interaction at the molecular level remains unexplored.
Aim. To conduct a pathophysiological analysis of the molecular mechanisms of three-component synergistic carcinogenesis.
Materials and methods. A narrative review was conducted in accordance with PRISMA-ScR guidelines using PubMed, Scopus, and Google Scholar databases (1986–2026). A total of 214 publications were identified.
Results. Four molecular convergence nodes were identified: (1) glucocorticoid receptor (GR)/aryl hydrocarbon receptor (AhR) competition for AhR nuclear translocator (ARNT) and CBP/p300 – a bidirectional molecular bridge between stress-induced and chemical carcinogenesis that blocks apoptosis regardless of the predominant ligand; (2) triple damage to TP53 – structural (radiation-induced double-strand break (DSB) translocations), functional (benzo[a]pyrene diol epoxide (BPDE) adducts at codons 157/248/273), and transcriptional (GR-Hdm2-mediated p53 degradation in the nucleus); (3) competitive depletion of proliferating cell nuclear antigen (PCNA)/replication protein A (RPA) among homologous recombination (HR), nucleotide excision repair (NER), and base excision repair (BER) pathways; (4) synergistic natural killer (NK)-surveillance blockade through additive immunosuppression from dioxins, age-related NK involution, and cortisol.
Conclusions. Three-component synergism is multiplicative: the expected relative risk of malignancy for the post-Chornobyl cohort may substantially exceed the risk associated with each individual component (conceptual estimate requiring prospective epidemiological verification). A peak increase in cancer incidence is projected for 2030–2035 in the post-Chornobyl cohort and for 2032–2038 in the general population. The model is conceptual and requires prospective verification in cohort studies.
References
Schwarz, M., Epe, B., Wohak, L. E., Voss, C., & Hartwig, (2026). The role of cytotoxicity in the process of carcinogenesis. Archives of Toxicology, 100(8), 3791-3799. https://doi.org/10.1007/s00204-026-04408-w
Kopp, W. (2026) The integrated theory of carcinogenesis: Cancer as dysregulated persistence under chronic systemic stress. Frontiers in Oncology, 16, 1811760. https://doi.org/10.3389/fonc.2026.1811760
Hennings, H., Glick, A. B., Greenhalgh, D. A., Morgan, D. L., Strickland, J. E., Tennenbaum, T., & Yuspa, S. (1993). Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proceedings of the Society for Experimental Biology and Medicine, 202(1), 1-8. https://doi.org/10.3181/00379727-202-43511a
Kwan, E. K., & Park, (2026). Hypoxic adaptation theory of cancer. Frontiers in Cell and Developmental Biology, 14, 1731939. https://doi.org/10.3389/fcell.2026.1731939
Zafar, S., Hafeez, A., et al. (2025). Emerging biomarkers for early cancer detection and diagnosis: Challenges, innovations, and clinical perspectives. European Journal of Medical Research, 30(1), 760. https://doi.org/10.1186/s40001-025-03003-6
Bussey, K. J., & Davies, P. C. W. (2021). Reverting to single-cell biology: The predictions of the atavism theory of cancer. Progress in Biophysics and Molecular Biology, 165, 49-55. https://doi.org/10.1016/j.pbiomolbio.2021.08.002
Celik-Uzuner, S., Nalkiran, I., Uzuner, U., & Sevim Nalkiran, H. (2026). Epigenetic and mitoepigenetic regulation in cancer and therapeutic perspectives. Frontiers in Pharmacology, 17, 1760013 https://doi.org/10.3389/ fphar.2026.1760013
Alonso-Curbelo, D., Ho, Y.-J., Burdziak, C., Maag, J. L. V., Morris, J. P., IV, Chandwani, R., Chen, H.-A., Tsanov, K. M., Barriga, F. M., Luan, W., Tasdemir, N., Livshits, G., Azizi, E., Chun, J., Wilkinson, J. E., Mazutis, L., Leach, S. D., Koche, R., Pe’er, D., & Lowe, S. W. (2021). A gene-environment-induced epigenetic program initiates tumorigenesis. Nature, 590(7847), 642-648. https://doi.org/10.1038/s41586-020-03147-x
Ki, M. R., Kim, D. H., Abdelhamid, M. A. A., & Pack, S. (2025). Cancer and aging biomarkers: Classification, early detection technologies and emerging research trends. Biosensors, 15(11), 737. https://doi.org/10.3390/bios15110737
Seno, M. (2025). A landscape of cancer initiation and cancer stem cells. Cancers, 17(2), 203. https://doi.org/10.3390/cancers17020203
International Agency for Research on Cancer. (2024). IARC monographs on the identification of carcinogenic hazards to humans (Vol. 134). International Agency for Research on Cancer. https://monographs.iarc.who.int
Bazyka D., Gudzenko, N., Dyagil, I., Ilienko, I., Belyi, D., Chumak, V., Prysyazhnyuk, A., &. Bakhanova, E. (2019). Cancers after Chornobyl: From epidemiology to molecular quantification. Cancers, 11(9), 1291. https://doi.org/10.3390/cancers11091291
Kyrylenko, Y.O., & Ziablitsev, S. V. (2026). Synergistic radiation- and chemical-induced carcinogenesis: Deficient DNA repair mechanisms in the post-Chornobyl cohort under wartime chemical exposures in Ukraine. In V. Shpak (Comp.), Chornobyl 40: Multidisciplinary perspectives on a global tragedy (pp. 5-13). GS Publishing Services. https://doi.org/10.51587/9798-9935-42812-2026-31
Kyrylenko, Y. O., & Ziablitsev, S. V. (2026). Carcinogenic consequences of missile and drone strikes in Ukraine: Fuel toxicology, mechanisms of carcinogenesis, and cancer incidence forecast (literature review). Medical Science of Ukraine, 22(1), 179-193. https://doi.org/10.32345/2664-4738.1.2026.21
Vignjević Petrinović, S., Milošević, M.S., Marković, D., & Momčilović, S. (2023). Interplay between stress and cancer – A focus on inflammation. Frontiers in Physiology, 14, 1119095 https://doi.org/10.3389/fphys.2023.1119095
He, Y., Yu, H., Li, F., Liu, J., Chen, Z., Zhu, W., Yang, L., & Yan, T. (2026). The crosstalk between nerves and immunity: Chronic stress as a driver of tumor progression. Frontiers in Immunology, 17, 1758894. https://doi.org/10.3389/fimmu.2026.1758894
Gruszczyk, J., Grandvuillemin, L., Lai-Kee-Him,, Paloni, M., Savva, C. G., Germain, P., Grimaldi, M., Boulahtouf, A., Kwong, H.-S., Bous, J., Ancelin, A., Bechara, C., Barducci, A., Balaguer, P., & Bourguet, W. (2022). Cryo-EM structure of the agonist-bound Hsp90-XAP2-AHR cytosolic complex. Nature Communications, 13(1), 7010. https://doi.org/ 10.1038/s41467-022-34773-w
Mandal, A., Biswas, N., & Alam, M. N. (2023). Implications of xenobiotic-response element(s) and aryl hydrocarbon receptor in health and diseases. Human Cell, 36(5),. 1638–1655. https://doi.org/10.1007/s13577-023-00931-5
Al-Dhfyan, A., Alaiya, A., Al-Mohanna,, et al. (2023). Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy. Journal of Advanced Research, 50,. 177–192. https://doi.org/10.1016/j.jare.2022.10.006
Piberger, A. L., Krüger, C. T., Strauch, B. M., Schneider, B., & Hartwig, A. (2018). BPDE-induced genotoxicity: Relationship between DNA adducts, mutagenicity in the in vitro PIG-A assay, and the transcriptional response to DNA damage in TK6 cells. Archives of Toxicology, 92, 541-551. https://doi.org/10.1007/s00204-017-2003-0
Bukowska, B., Mokra, K., & Michałowicz, J. (2022). Benzo[a]pyrene-Environmental occurrence, human exposure, and mechanisms of toxicity. International Journal of Molecular Sciences, 23(11), 6348. https://doi.org/10.3390/ijms23116348
Prabhu, K. S., Therachiyil, L., Masoodi, T., Bhat, A. A., & Uddin, S. (2025). GADD45: A crucial component of the DNA damage response and a potential cancer therapeutic target. Expert Opinion on Therapeutic Targets, 29(10), 743-756. https://doi.org/10.1080/14728222.2025.2589807
Kanter, N. G., Cohen-Woods, S., Balfour, D., Burt, M. G., Waterman, A. L., & Koczwara, B. (2024). Hypothalamic–pituitary–adrenal axis dysfunction in people with cancer: A systematic review. Cancer Medicine, 13(22), e70366. https://doi.org/10.1002/cam4.70366
Opitz, C. A., Holfelder, P., Prentzell, M. T., & Trump, S. (2023). The complex biology of aryl hydrocarbon receptor activation in cancer and beyond. Biochemical Pharmacology, 216, 115798 https://doi.org/10.1016/j.bcp.2023.115798
Sato, S., Shirakawa, H., Tomita, S., Tohkin, M., Gonzalez, F. J., & Komai, M. (2013) The aryl hydrocarbon receptor and glucocorticoid receptor interact to activate human metallothionein 2A. Toxicology and Applied Pharmacology, 273(1), 90-99. https://doi.org/10.1016/j.taap.2013.08.017
Michalek, J. E., Pirkle, J. L., Caudill, S. P., Tripathi, R. C., Patterson, D. G., Jr., & Needham, L. L. (1996). Pharmacokinetics of TCDD in veterans of Operation Ranch Hand: 10-year follow-up. Journal of Toxicology and Environmental Health, 47(3), 209-220. https://doi.org/10.1080/009841096161744
Chang, H. H. Y., Pannunzio, N. R., Adachi, N., & Lieber, M. R. (2017). Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nature Reviews Molecular Cell Biology, 18(8), 495-506 https://doi.org/10.1038/nrm.2017.48
Brenner, A. V., Tronko, M. D., Hatch, M., Bogdanova, T. I., Oliynik, V. A., Lubin, J. H., Zablotska, L. B., Tereschenko, V. P., McConnell, R. J., Zamotaeva, G. A., O’Kane, P., Bouville, A. C., Chaykovskaya, L. V., Greenebaum, E., Paster, I. P., Shpak, V. M., & Ron, E. (2011). I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environmental Health Perspectives, 119(7), 933-939. https://doi.org/10.1289/ehp.1002674
Morton, L. M., Karyadi, D. M., Stewart, C., Bogdanova, T. I., Dawson, E. T., Steinberg, M. K., Dai, J., Hartley, S. W., Schonfeld, S.J., Sampson, J. N., Maruvka, Y. E., Kapoor, V., Ramsden, D. A., Carvajal-Garcia, J., Perou, C. M., Parker, J. S., Krznaric, M., Yeager, M., Boland, J. F., Hutchinson, A., Hicks, B. D., Dagnall, C. L., Gastier-Foster, J. M., Bowen, J., Lee, O., Machiela, M. J., Cahoon, E. K., Brenner, A. V., Mabuchi, K., Drozdovitch, V., Masiuk, S., Chepurny, M., Zurnadzhy, L. Yu., Hatch,M., Berrington de Gonzalez, A., Thomas, G. A., Tronko, M. D., Getz, G., & Chanock, S. J. (2021). Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science, 372(6543), eabg2538. https://doi.org/10.1126/science.abg2538
Patel, A. B., Shaikh, S., Jain, K. R., Desai, C., & Madamwar, D. (2020). Polycyclic aromatic hydrocarbons: Sources, toxicity, and remediation approaches. Frontiers in Microbiology, 11, 562813. https://doi.org/10.3389/fmicb.2020.562813
Tornesello, M. L. (2025). TP53 mutations in cancer: Molecular features and therapeutic opportunities (Review). International Journal of Molecular Medicine, 55(1), 7. https://doi.org/10.3892/ijmm.2024.5448
Sengupta, S., & Wasylyk, B. (2001). Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes & Development, 15(18), 2367-2380. https://doi.org/10.1101/gad.202201
Henningsen, K. M., Manzini, V., Magerhans, A., Gerber, S., & Dobbelstein, M. (2022). MDM2-driven ubiquitination rapidly removes p53 from its cognate promoters. Biomolecules, 12(1), 22. https://doi.org/10.3390/biom12010022
Barnoud, T., Indeglia, A., & Murphy, M. E. (2021). Shifting the paradigms for tumor suppression: Lessons from the p53 field. Oncogene, 40(25), 4281-4290. https://doi.org/10.1038/s41388-021-01852-z
Moldovan, G. L., Pfander, B., & Jentsch, S. (2007). PCNA, the maestro of the replication fork. Cell, 129(4), 665-679. https://doi.org/10.1016/j.cell.2007.05.003
Nickoloff, J. A., et al. (2021). Nuclease cleavage at the intersection of DNA replication and repair. Frontiers in Molecular Biosciences, 8, 824997. https://doi.org/10.3389/fmolb.2021.824997
Lloyd, D. C., et al. (1995). Survey of chromosomal aberrations in lymphocytes of Chernobyl liquidators. Radiation Protection Dosimetry, 58(2), 85-91. https://doi.org/10.1093/oxfordjournals.rpd.a062426
Hemmaphan, S., & Bordeerat, N. K. (2022). Genotoxic effects of lead and their impact on the expression of DNA repair genes. International Journal of Environmental Research and Public Health, 19(7), 4307. https://doi.org/10.3390/ijerph19074307
Nagaraju, R., Kalahasthi, R., Balachandar, R., & Bagepally, B. S. (2022). Association between lead exposure and DNA damage (genotoxicity): Systematic review and meta-analysis. Archives of Toxicology, 96(11), 2899-2911. https://doi.org/10.1007/s00204-022-03352-9
Flaherty, R. L., Owen, M., Fagan-Murphy, A., Intabli, H., Healy, D., Patel, A., Allen, M. C., Patel, B. A., & Flint, M. S. (2017). Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer. Breast Cancer Research, 19(1), 35. https://doi.org/10.1186/s13058-017-0823-8
López-Gil, L., Pascual-Ahuir, A., & Proft, M. (2023). Genomic instability and epigenetic changes during aging. International Journal of Molecular Sciences, 24(18), 14279. https://doi.org/10.3390/ijms241814279
Gergues, M., Bari, R., Koppisetti,, Gosiewska, A., Kang, L., & Hariri, R. J. (2025). Senescence, NK cells, and cancer: Navigating the crossroads of aging and disease. Frontiers in Immunology, 16,1565278. https://doi.org/10.3389/fimmu.2025.1565278
Wei, Q., Liang, G., Zeng, R., Li, Y., Hong, A., Wang, H., Feng, S., Wang, Y., & Wang, Y. (2026) Glucocorticoid receptor activation reprograms NK cells to drive AREG-mediated immunosuppression: A pan-cancer role for AREG. Advanced Science. https://doi.org/10.1002/advs.202512620
Yang, J., & Jiang, W. (2023). A meta-analysis of the association between post-traumatic stress disorder and cancer risk. Frontiers in Psychiatry, 14, 1281606. https://doi.org/10.3389/fpsyt.2023.1281606
Little, M. P., Eidemüller, M., Kaiser, J. C., & Apostoaei, A. I. (2024). Minimum latency effects for cancer associated with exposures to radiation or other carcinogens. British Journal of Cancer, 130(5), 819-829. https://doi.org/10.1038/s41416-023-02544-z
Chiorcea-Paquim, A.-M. (2022). 8-Oxoguanine and 8-oxodeoxyguanosine biomarkers of oxidative DNA damage: A review on HPLC-ECD determination. Molecules, 27(5), 1620. https://doi.org/10.3390/molecules2705162
Iftikhar, A., Shepherd, S., Jones, S., & Ellis, (2024). Effect of mifepristone on migration and proliferation of oral cancer cells. International Journal of Molecular Sciences, 25(16), 8777. https://doi.org/10.3390/ijms25168777
Serritella, A. V., Shevrin, D., Heath, E. I., et al. (2022). Phase I/II trial of enzalutamide and mifepristone, a glucocorticoid receptor antagonist, for metastatic castration-resistant prostate cancer. Clinical Cancer Research, 28(8), 1549-1559. https://doi.org/10.1158/1078-0432.CCR-21-4049
Wolf, A. M. D., Oeffinger, K. C., Shih, T. Y.-C., Walter, L. C., Church, T. R., Fontham, E. T. H., Elkin, E. B., Etzioni, R. D., Guerra, C. E., Perkins, R. B., Kondo, K. K., Kratzer, T. B., Manassaram-Baptiste, D., Dahut, W. L., & Smith, R. A. (2024). Screening for lung cancer: 2023 guideline update from the American Cancer Society. CA: A Cancer Journal for Clinicians, 74(1), 50-81 https://doi.org/10.3322/caac.21811
US Preventive Services Task Force, Nicholson, W. K., Silverstein, M., Wong, J. B., Barry, M.J., Chelmow, D., Coker, T, R., Davis, E. M., Jaén, C. R., Krousel-Wood, M., Lee, S., Li, L., Mangione, C. M., Rao, G., Ruiz, J. M., Stevermer, J. J., Tsevat, J., Underwood, S. M., & Wiehe, S. (2024). Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA, 331(22), 1918-1930 https://doi.org/10.1001/jama.2024.5534

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

